MYCN and neuroblastoma: The enhanced sensitivity of MYCN overexpressing neuroblastoma cell lines to PI3K/mTOR inhibition is somewhat surprising, since these cells lack intrinsic mutations in the PI3K pathway members PTEN or PIK3CA.